130 related articles for article (PubMed ID: 25416563)
41. Analysis of the cost-effectiveness of dronedarone versus amiodarone, propafenone, and sotalol in patients with atrial fibrillation: results for Serbia.
Tesic D; Kostic M; Paunovic D; Jankovic SM
Kardiol Pol; 2015; 73(4):287-95. PubMed ID: 25428811
[TBL] [Abstract][Full Text] [Related]
42. Interventions to prevent postoperative atrial fibrillation in Dutch cardiothoracic centres: a survey study.
Emiola A; Kluin J; El Mathari S; de Groot JR; van Boven WJ;
Neth Heart J; 2024 Apr; 32(4):173-181. PubMed ID: 38358408
[TBL] [Abstract][Full Text] [Related]
43. Ranolazine: An Old Drug with Emerging Potential; Lessons from Pre-Clinical and Clinical Investigations for Possible Repositioning.
Rouhana S; Virsolvy A; Fares N; Richard S; Thireau J
Pharmaceuticals (Basel); 2021 Dec; 15(1):. PubMed ID: 35056088
[TBL] [Abstract][Full Text] [Related]
44. Calcium Signaling Silencing in Atrial Fibrillation: Implications for Atrial Sodium Homeostasis.
Kaplan AD; Joca HC; Boyman L; Greiser M
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638854
[TBL] [Abstract][Full Text] [Related]
45. Postoperative Atrial Fibrillation Following Cardiac Surgery: From Pathogenesis to Potential Therapies.
Rezaei Y; Peighambari MM; Naghshbandi S; Samiei N; Ghavidel AA; Dehghani MR; Haghjoo M; Hosseini S
Am J Cardiovasc Drugs; 2020 Feb; 20(1):19-49. PubMed ID: 31502217
[TBL] [Abstract][Full Text] [Related]
46. Ranolazine: Multifaceted Role beyond Coronary Artery Disease, a Recent Perspective.
Ghosh GC; Ghosh RK; Bandyopadhyay D; Chatterjee K; Aneja A
Heart Views; 2018; 19(3):88-98. PubMed ID: 31007857
[TBL] [Abstract][Full Text] [Related]
47. Ranolazine for Prevention of Atrial Fibrillation after Cardiac Surgery: A Systematic Review.
Patel N; Kluger J
Cureus; 2018 May; 10(5):e2584. PubMed ID: 30009098
[TBL] [Abstract][Full Text] [Related]
48. Impact of ranolazine on ventricular arrhythmias - A systematic review.
Bazoukis G; Tse G; Letsas KP; Thomopoulos C; Naka KK; Korantzopoulos P; Bazoukis X; Michelongona P; Papadatos SS; Vlachos K; Liu T; Efremidis M; Baranchuk A; Stavrakis S; Tsioufis C
J Arrhythm; 2018 Apr; 34(2):124-128. PubMed ID: 29657587
[TBL] [Abstract][Full Text] [Related]
49. Atrial fibrillation after cardiac surgery: Prevention and management: The Australasian experience.
Alawami M; Chatfield A; Ghashi R; Walker L
J Saudi Heart Assoc; 2018 Jan; 30(1):40-46. PubMed ID: 29296063
[TBL] [Abstract][Full Text] [Related]
50. Antiarrhythmic Effects of Combining Dofetilide and Ranolazine in a Model of Acutely Induced Atrial Fibrillation in Horses.
Carstensen H; Kjær L; Haugaard MM; Flethøj M; Hesselkilde EZ; Kanters JK; Pehrson S; Buhl R; Jespersen T
J Cardiovasc Pharmacol; 2018 Jan; 71(1):26-35. PubMed ID: 29068807
[TBL] [Abstract][Full Text] [Related]
51. Ranolazine: safe and effective in a patient with hypertensive cardiomyopathy and multiple episodes of electrical storm.
Margos P; Margos N; Mokadem N; Patsiotis I; Kranidis A
Clin Case Rep; 2017 Jul; 5(7):1170-1175. PubMed ID: 28680620
[TBL] [Abstract][Full Text] [Related]
52. Ranolazine: A Contemporary Review.
Rayner-Hartley E; Sedlak T
J Am Heart Assoc; 2016 Mar; 5(3):e003196. PubMed ID: 26979079
[No Abstract] [Full Text] [Related]
53. Ranolazine in Cardiac Arrhythmia.
Saad M; Mahmoud A; Elgendy IY; Richard Conti C
Clin Cardiol; 2016 Mar; 39(3):170-8. PubMed ID: 26459200
[TBL] [Abstract][Full Text] [Related]
54. Monocyte-platelet aggregates and CD11b expression as markers for thrombogenicity in atrial fibrillation.
Pfluecke C; Tarnowski D; Plichta L; Berndt K; Schumacher P; Ulbrich S; Forkmann M; Christoph M; Poitz DM; Wunderlich C; Strasser RH; Ibrahim K
Clin Res Cardiol; 2016 Apr; 105(4):314-22. PubMed ID: 26411420
[TBL] [Abstract][Full Text] [Related]
55. Short-course of ranolazine prevents postoperative atrial fibrillation following coronary artery bypass grafting and valve surgeries.
Hammond DA; Smotherman C; Jankowski CA; Tan S; Osian O; Kraemer D; DeLosSantos M
Clin Res Cardiol; 2015 May; 104(5):410-7. PubMed ID: 25416563
[TBL] [Abstract][Full Text] [Related]
56. A propensity-score matched analysis on the impact of postoperative atrial fibrillation on the early and late outcomes after concomitant aortic valve replacement and coronary artery bypass graft surgery.
Saxena A; Shi WY; Paramanathan A; Herle P; Dinh D; Smith JA; Reid CM; Shardey G; Newcomb AE
J Cardiovasc Med (Hagerstown); 2014 Mar; 15(3):199-206. PubMed ID: 24572338
[TBL] [Abstract][Full Text] [Related]
57. Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting Surgery.
Ferreira AF; A Saraiva F; Moreira R; J Cerqueira R; J Amorim M; Pinho P; P Lourenço A; F Leite-Moreira A
Rev Port Cir Cardiotorac Vasc; 2017; 24(3-4):129. PubMed ID: 29701361
[TBL] [Abstract][Full Text] [Related]
58. Comparison of effectiveness and safety of ranolazine versus amiodarone for preventing atrial fibrillation after coronary artery bypass grafting.
Miles RH; Passman R; Murdock DK
Am J Cardiol; 2011 Sep; 108(5):673-6. PubMed ID: 21726841
[TBL] [Abstract][Full Text] [Related]
59. Efficacy of ranolazine in preventing atrial fibrillation following cardiac surgery: Results from a meta-analysis.
Trivedi C; Upadhyay A; Solanki K
J Arrhythm; 2017 Jun; 33(3):161-166. PubMed ID: 28607609
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
